LEUKEMIA RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$10,265,211
Cash & Equivalents
48%
Investments
39%
Receivables (Non-Related)
8%
Other Assets
5%
Prepaid Expenses
<1%
Inventories
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Liabilities in 2025 (Year End)
$3,040,287
Grants Payable
93%
Deferred Revenue
5%
Other Liabilities
2%
Payables & Accruals
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$4,740,707
$4,908,898
+4%
Receivables (Non-Related)
$305,038
$792,095
+160%
Related-Party Receivables
-
-
-
Inventories
-
$13,454
-
Prepaid Expenses
$8,512
$27,480
+223%
Investments
$1,306,806
$3,999,153
+206%
Property, Plant, & Equipment (net)
$1,655
$997
-40%
Other Assets
$519,355
$523,134
+1%
Total Assets
$6,882,073
$10,265,211
+49%
Liabilities
2024
2025
Change
Payables & Accruals
$14,300
$14,326
+0%
Grants Payable
$2,685,682
$2,814,077
+5%
Deferred Revenue
-
$152,460
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$95,429
$59,424
-38%
Total Liabilities
$2,795,411
$3,040,287
+9%
Net assets
2024
2025
Change
Restricted Net Assets
$530,966
$549,928
+4%
Unrestricted Net Assets
$3,555,696
$6,674,996
+88%
Net assets
2024
2025
Change
Net assets
+$4,086,662
+$7,224,924
+77%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)